Wells Fargo & Company Axcella Health Inc. Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$0.22 - $0.46 $503 - $1,052	-2,287 Reduced 88.13%	308 $0
Q1 2023 May 12, 2023	BUY	$0.31 - $0.77 $1 - $3	4 Added 0.15%	2,595 $1,000
Q4 2022 Feb 13, 2023	BUY	$0.16 - $1.1 $183 - $1,262	1,148 Added 79.56%	2,591 $0
Q3 2022 Nov 14, 2022	SELL	$1.62 - $2.73 $105 - $177	-65 Reduced 4.31%	1,443 $2,000
Q2 2022 Aug 12, 2022	BUY	$1.41 - $2.77 $566 - $1,113	402 Added 36.35%	1,508 $3,000
Q1 2022 May 16, 2022	SELL	$1.58 - $2.82 $472 - $843	-299 Reduced 21.28%	1,106 $3,000
Q4 2021 Feb 14, 2022	BUY	$2.06 - $3.61 $618 - $1,083	300 Added 27.15%	1,405 $3,000
Q3 2021 Nov 15, 2021	SELL	$2.98 - $4.31 $26 - $38	-9 Reduced 0.81%	1,105 $3,000
Q2 2021 Aug 16, 2021	SELL	$3.08 - $5.13 $14,611 - $24,336	-4,744 Reduced 80.98%	1,114 $4,000
Q1 2021 May 13, 2021	SELL	$4.55 - $6.72 $66,652 - $98,441	-14,649 Reduced 71.43%	5,858 $28,000
Q4 2020 Feb 09, 2021	BUY	$4.24 - $5.97 $17,180 - $24,190	4,052 Added 24.62%	20,507 $107,000
Q3 2020 Nov 05, 2020	SELL	$4.12 - $5.91 $4,482 - $6,430	-1,088 Reduced 6.2%	16,455 $76,000
Q2 2020 Aug 13, 2020	BUY	$2.94 - $7.7 $16,772 - $43,928	5,705 Added 48.19%	17,543 $98,000
Q1 2020 May 14, 2020	BUY	$2.25 - $5.24 $26,635 - $62,031	11,838 New	11,838 $40,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.